Apic Bio

Developer of gene therapies for rare diseases

placeCambridge, Massachusetts, United States calendar_todayFounded 2017 groups30 employees language apic-bio.com

Registered entities

Innovation

1 patent family — focus: Chemistry & metallurgy; filing pace steady. Cited 9 times.

YearFilings
20231
20241

Investor mix

4 investors on record; lead investors include The Alpha-1 Project, Morningside.

Investor typeCountShare
Venture capital250%
Other / undisclosed250%
Coming soon